Search Results

There are 28011 results for: content related to: A Simple One-Pot Dehydration Process to Convert N -acetyl- D -glucosamine into a Nitrogen-Containing Compound, 3-acetamido-5-acetylfuran

  1. Combined Experimental and Computational Studies on the Physical and Chemical Properties of the Renewable Amide, 3-Acetamido-5-acetylfuran


    Volume 15, Issue 18, December 15, 2014, Pages: 4087–4094, Yi Liu, Prof. Christopher N. Rowley and Prof. Francesca M. Kerton

    Version of Record online : 24 OCT 2014, DOI: 10.1002/cphc.201402376

  2. Shell Biorefinery: Dream or Reality?

    Chemistry - A European Journal

    Volume 22, Issue 38, September 12, 2016, Pages: 13402–13421, Xi Chen, Huiying Yang and Prof. Ning Yan

    Version of Record online : 3 AUG 2016, DOI: 10.1002/chem.201602389

  3. Effect of Treatment Methods on Chitin Structure and Its Transformation into Nitrogen-Containing Chemicals


    Volume 80, Issue 10, October 2015, Pages: 1565–1572, Xi Chen, Dr. Yongjun Gao, Dr. Lan Wang, Prof. Hongzhang Chen and Prof. Ning Yan

    Version of Record online : 7 SEP 2015, DOI: 10.1002/cplu.201500326

  4. You have free access to this content
    Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles

    British Journal of Clinical Pharmacology

    Volume 69, Issue 6, June 2010, Pages: 593–597, Hiroshi Yamazaki, Minako Nakamoto, Makiko Shimizu, Norie Murayama and Toshiro Niwa

    Version of Record online : 26 FEB 2010, DOI: 10.1111/j.1365-2125.2010.03656.x

  5. CYP3A5 Genotype has a Dose-dependent Effect on ABT-773 Plasma Levels

    Clinical Pharmacology & Therapeutics

    Volume 75, Issue 6, June 2004, Pages: 516–528, David A. Katz, David R. Grimm, Steven C. Cassar, Maria C. Gentile, Xin Ye, Matthew J. Rieser, Eric F. Gordon, Jill E. Polzin, Linda E. Gustavson, Rita M. Driscoll, Robert F. O'Dea, Laura A. Williams and Stanley Bukofzer

    Version of Record online : 28 JUN 2004, DOI: 10.1016/j.clpt.2004.01.013

  6. You have free access to this content
    Significantly reduced cytochrome P450 3A4 expression and activity in liver from humans with diabetes mellitus

    British Journal of Pharmacology

    Volume 163, Issue 5, July 2011, Pages: 937–947, Miroslav Dostalek, Michael H. Court, Bingfang Yan and Fatemeh Akhlaghi

    Version of Record online : 8 JUN 2011, DOI: 10.1111/j.1476-5381.2011.01270.x

  7. Measurement and Compartmental Modeling of the Effect of CYP3A5 Gene Variation on Systemic and Intrarenal Tacrolimus Disposition

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 6, December 2012, Pages: 737–745, S Zheng, Y Tasnif, M F Hebert, C L Davis, Y Shitara, J C Calamia, Y S Lin, D D Shen and K E Thummel

    Version of Record online : 17 OCT 2012, DOI: 10.1038/clpt.2012.175

  8. The Effect of CYP3A5 and MDR1 Polymorphic Expression on Cyclosporine Oral Disposition in Renal Transplant Patients

    The Journal of Clinical Pharmacology

    Volume 43, Issue 6, June 2003, Pages: 555–564, Dr Charles R. Yates, Wenhui Zhang, Pengfei Song, Shen Li, Dr A. Osama Gaber, Dr Malak Kotb, Dr Marsha R. Honaker, Dr Rita R. Alloway and Dr Bernd Meibohm

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003253617

  9. Influence of CYP3A5 Genotype on the Pharmacokinetics and Pharmacodynamics of the Cytochrome P4503A Probes Alfentanil and Midazolam

    Clinical Pharmacology & Therapeutics

    Volume 82, Issue 4, October 2007, Pages: 410–426, E D Kharasch, A Walker, N Isoherranen, C Hoffer, P Sheffels, K Thummel, D Whittington and D Ensign

    Version of Record online : 6 JUN 2007, DOI: 10.1038/sj.clpt.6100237

  10. CYP3A5 regulates prostate cancer cell growth by facilitating nuclear translocation of AR

    The Prostate

    Volume 75, Issue 5, April 1, 2015, Pages: 527–538, Ranjana Mitra and Oscar B. Goodman Jr

    Version of Record online : 13 JAN 2015, DOI: 10.1002/pros.22940

  11. You have free access to this content
    Dynamic effects of CYP3A5 polymorphism on dose requirement and trough concentration of tacrolimus in renal transplant recipients

    Journal of Clinical Pharmacy and Therapeutics

    Volume 42, Issue 1, February 2017, Pages: 93–97, P. Chen, J. Li, J. Li, R. Deng, Q. Fu, J. Chen, M. Huang, X. Chen and C. Wang

    Version of Record online : 25 NOV 2016, DOI: 10.1111/jcpt.12480

  12. CYP3A pharmacogenetics and tacrolimus disposition in adult heart transplant recipients

    Clinical Transplantation

    Volume 30, Issue 9, September 2016, Pages: 1074–1081, Kimberly M. Deininger, Anh Vu, Robert L. Page II, Amrut V. Ambardekar, JoAnn Lindenfeld and Christina L. Aquilante

    Version of Record online : 11 JUL 2016, DOI: 10.1111/ctr.12790

  13. Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism – a prospective, randomized, controlled study

    Clinical Transplantation

    Volume 27, Issue 3, May/June 2013, Pages: E272–E281, Si-Yang Chen, Jia-Li Li, Fan-Hang Meng, Xue-Ding Wang, Tao Liu, Jun Li, Long-Shan Liu, Qian Fu, Min Huang and Chang-Xi Wang

    Version of Record online : 24 FEB 2013, DOI: 10.1111/ctr.12101

  14. You have free access to this content
    Impact of genetic polymorphisms on tacrolimus pharmacokinetics and the clinical outcome of renal transplantation

    Transplant International

    Volume 25, Issue 4, April 2012, Pages: 471–480, Guillermo Gervasini, Montserrat Garcia, Rosa María Macias, Juan Jose Cubero, Francisco Caravaca and Julio Benitez

    Version of Record online : 28 FEB 2012, DOI: 10.1111/j.1432-2277.2012.01446.x

  15. You have full text access to this OnlineOpen article
    Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation

    Transplant International

    Volume 26, Issue 12, December 2013, Pages: 1198–1207, Anders Åsberg, Karsten Midtvedt, Mike van Guilder, Elisabet Størset, Sara Bremer, Stein Bergan, Roger Jelliffe, Anders Hartmann and Michael N. Neely

    Version of Record online : 15 OCT 2013, DOI: 10.1111/tri.12194

  16. CYP3A5 genotypes affect tacrolimus pharmacokinetics and infectious complications in Chinese pediatric liver transplant patients

    Pediatric Transplantation

    Volume 18, Issue 2, March 2014, Pages: 166–176, Feng Xue, Longzhi Han, Yikuan Chen, Zhifeng Xi, Qigen Li, Ning Xu, Yun Xia, Katie Streicher, Jianjun Zhang and Qiang Xia

    Version of Record online : 20 JAN 2014, DOI: 10.1111/petr.12216

  17. Influence of CYP3A5 genotypes on tacrolimus dose requirement: age and its pharmacological interaction with ABCB1 genetics in the Chinese paediatric liver transplantation

    International Journal of Clinical Practice

    Volume 69, Issue S183, May 2015, Pages: 53–62, T.-H. Yang, Y.-K. Chen, F. Xue, L.-Z. Han, C.-H. Shen, T. Zhou, Y. Luo, J.-J. Zhang and Q. Xia

    Version of Record online : 5 MAY 2015, DOI: 10.1111/ijcp.12667

  18. Effect of CYP3A5 polymorphism on the pharmacokinetics of tacrolimus and acute rejection in renal transplant recipients: experience at a single centre

    International Journal of Clinical Practice

    Volume 69, Issue S183, May 2015, Pages: 16–22, Y. Cheng, H. Li, Y. Meng, H. Liu, L. Yang, T. Xu, J. Yu, N. Zhao and Y. Liu

    Version of Record online : 5 MAY 2015, DOI: 10.1111/ijcp.12662

  19. Significant impacts of CYP3A4*1G and CYP3A5*3 genetic polymorphisms on the pharmacokinetics of diltiazem and its main metabolites in Chinese adult kidney transplant patients

    Journal of Clinical Pharmacy and Therapeutics

    Volume 41, Issue 3, June 2016, Pages: 341–347, L.-Y. Zhou, X.-C. Zuo, K. Chen, J.-L. Wang, Q.-J. Chen, Y.-N. Zhou, H. Yuan, Y. Ma, L.-J. Zhu, Y.-X. Peng and Y.-Z. Ming

    Version of Record online : 5 MAY 2016, DOI: 10.1111/jcpt.12394

  20. CYP3A5 and CYP3A4 but not MDR1 Single-nucleotide Polymorphisms Determine Long-term Tacrolimus Disposition and Drug-related Nephrotoxicity in Renal Recipients

    Clinical Pharmacology & Therapeutics

    Volume 82, Issue 6, December 2007, Pages: 711–725, D R J Kuypers, H de Jonge, M Naesens, E Lerut, K Verbeke and Y Vanrenterghem

    Version of Record online : 9 MAY 2007, DOI: 10.1038/sj.clpt.6100216